Liquid-transfer adapter beveled spike

Information

  • Patent Grant
  • 10568809
  • Patent Number
    10,568,809
  • Date Filed
    Friday, December 18, 2015
    8 years ago
  • Date Issued
    Tuesday, February 25, 2020
    4 years ago
Abstract
A liquid-transfer adapter operatively interposable between an injector and a vial is provided. The adapter has an injector engaging portion configured for fluidly coupling to an injector and a vial coupling. The vial coupling includes a spike that has a spike axis and a tip portion configured for piercing a septum of a vial. The tip portion includes a plurality of facets that meet each other at one or more edges and at least one of the one or more edges is sloped with respect to the spike axis. The spike defines a channel extending therethrough in fluid communication with the injector engaging portion. A channel opening is defined in at least one of the facets and disposed without interrupting the edges.
Description
TECHNICAL FIELD

The present application related generally to liquid-transfer adapters and, more specifically, to liquid-transfer adapters that provide liquid communication between vials and injectors.


BACKGROUND

In the medical field, it is common practice for medication to be provided in a vial. The medication is transferred from the vial to an injector (e.g., a syringe, auto-injector, jet injector, and so forth) for subsequent injection into a patient. In some cases, the medication is provided in a liquid solution in the sealed vial, while in other cases it is provided in a solid form (e.g., powder). Generally, when provided in solid form, a solvent (e.g., water) is inserted into the vial to dissolve the medication. The liquid medication is extracted out of the vial into an injector for injection into a patient.


A typical vial is sealed with a stopper that has sidewalls extending down the inside walls of a neck portion of the vial. Conventionally, a hollow spike has been implemented to provide fluid communication with the contents of the vial. In particular, the hollow spike punctures the stopper to insert and/or extract liquid from the vial. Occasionally, however, when attempting to puncture the stopper, the spike may inadvertently enter into a sidewall of the stopper, preventing or limiting liquid communication with the contents of the vials, depending on the orientation of the opening to draw the fluid from the vial into the spike.


Additionally, as conventional spikes are pushed through rubber stoppers, the rubber stoppers are often stretched, torn, or cut by the spike. In some cases portions of the stopper may enter into the hollow spike and may even core the stopper resulting in obstruction of liquid flow from the vial.


U.S. Pat. No. 5,254,106 discloses a needle that includes a slot that extends along the sidewalls of the needle. Similarly, U.S. Pat. Pub. No. 2006/0266431 discloses a needle with slots in the sidewall. U.S. Pat. No. 4,411,661 and U.S. Pat. Pub. No. 2007/0179506 disclose a spike with a slot that extends from a conical tip on its sidewalls. U.S. Pat. No. 7,150,735 discloses a spike with one or more openings in a beveled surface.


SUMMARY

A liquid-transfer adapter operatively interposable between an injector and a vial is provided. In some embodiments, the adapter has an injector engaging portion configured for fluidly coupling to an injector and a vial coupling. The vial coupling includes a spike that has a spike axis and a tip portion configured for piercing a septum of a vial. The tip portion includes a plurality of facets that meet each other at one or more edges and at least one of the one or more edges is sloped with respect to the spike axis. The spike defines a channel extending therethrough in fluid communication with the injector engaging portion. A channel opening is defined in at least one of the facets and disposed without interrupting the edges.


In some embodiments, the edges comprise junctions between the facets. The edges may also have cutting surfaces configured for cutting the septum as the spike is pushed therethrough. In one embodiment, the tip portion has at least three facets and the channel opening comprises a channel opening disposed in each of at least three of the facets. The channel the openings may be spaced circumferentially from the edges. Additionally, lateral edges of the channel openings may be disposed radially inward compared to the edges. Moreover, lateral edges of the channel openings are disposed radially inward relative to the edges at any axial position. The lateral edges of the channel openings may be spaced from the edges sufficiently to minimize intrusion of the septum into the channel openings when the spike is pierced through the septum. The channel openings may be substantially centered circumferentially on the facets. In some embodiments, a seal may be disposed at the injector engaging portion configured for mating with the injector for maintaining liquid within the channel and injector. Additionally, the injector engaging portion has dimensions suitable for coupling with a needle free injector. Moreover, a removable insert may be removably coupled within the injector engaging portion for selectively configuring the injector engaging portion for engaging variously sized injectors. The removable insert may have dimensions suitable for coupling with a syringe having a first width, and with the insert removed, the injector engaging portion is configured for coupling to a jet injector having a second width that is larger than the first width.


In some embodiments, a vial engaging member may be associated with the vial coupling portion and configured for engaging the adapter to the vial with the spike inserted therein. Moreover, the vial engaging member may include reflexed fingers arranged around the spike and extending theretowards for snapping to and retaining the adapter engaged to the vial. Further, the spike may include a shaft extending from the tip towards the injector engaging portion and an opening extends onto the shaft for maximizing fluid extraction from the vial with the vial in an inverted position.


In some embodiments, the edges meet at a point that is substantially axially centered. Additionally, the facets may be substantially flat bevels. In still other embodiments, a liquid-transfer adapter is provided having a spike for providing liquid communication to a sealed vial. The spike includes a shaft portion and a piercing point configured for piercing a septum of a vial. The tip includes at least three bevels joining together at a substantially centered tip, a channel extending through the spike, and a channel opening disposed within each bevel and onto the shaft portion. The channel openings are connected to the channel for transferring fluid to or from the vial.





BRIEF DESCRIPTION OF THE DRAWINGS

The drawings depict one or more implementations in accordance with the present concepts, by way of example only, not by way of limitation. In the drawings, like reference numerals refer to the same or similar elements.



FIG. 1 shows a liquid-transfer system in accordance with an example embodiment;



FIG. 2 is a cross-sectional view of the liquid-transfer system of FIG. 1 taken along line II-II;



FIG. 3 is a cross-section view of a distal portion of the distal end of the adapter of FIG. 2 coupled to a vial;



FIGS. 4-5 illustrate the vial before and after being sealed with a stopper 132, respectively;



FIGS. 6-8 are cross-sectional views of various adapter configurations to connect to various sizes of vials for liquid-transfer;



FIG. 9 is a perspective view of the liquid-transfer adapter of FIG. 1;



FIG. 10 is an enlarged cross-sectional view of the liquid-transfer adapter of FIG. 9 taken along line X-X;



FIG. 11 is an axial view of the adapter of FIG. 9 from a vial coupling end;



FIG. 12 illustrates a side view of the adapter of FIG. 1 having a cap prior to use of the adapter;



FIG. 13 is a cross-sectional view of the adapter shown in FIG. 12 taken along line XIV;



FIGS. 14-17 illustrate steps in an embodiment of a method of inserting liquid into the vial using the adapter;



FIG. 18 is a perspective view of an embodiment of a spike penetrating a septum of a vial;



FIGS. 19 and 20 are axial views of the spike of FIG. 18 partially and completely, respectively, penetrating through the septum of a vial; and



FIG. 21 illustrates a spike having four facets in accordance with and alternative embodiment.





DETAILED DESCRIPTION

Referring to FIG. 1, a liquid-transfer system 100 is illustrated in accordance with an example embodiment. Generally, the liquid-transfer system 100 includes a vial 102 holding liquid 103, a liquid-transfer adapter 104 and an injector 106. The liquid-transfer adapter 104 provides liquid communication between the vial 102 and the injector 106 to facilitate the transfer of liquid to and/or from the vial 102, and to and/or from the injector 106.


The injector 106 may have an indicator window 108 for indicating a volume of liquid 103 that it contains (e.g., the amount of liquid retrieved from the vial 102). The injector 106 may take one of several different forms, including a syringe, an auto injector, or a jet injector (needle free or needle-assisted). Information regarding injectors may be found in U.S. Pat. Nos. 5,875,976, 6,673,035, and/or 6,673,035, which are incorporated by reference herein in their entirety and for all purposes. It should be appreciated that the needle-free injectors described in these references can be adapted for needle-assisted injection, auto injection, and/or other types of injection.


The liquid-transfer adapter 104 can be operatively coupled in between the vial 102 and the injector 106. The liquid-transfer adapter 104 has a vial engaging end 110 that receives the vial 102 and couples the vial with the liquid-transfer adapter. Additionally, the liquid-transfer adapter 104 has an injector engaging end 112 to which the injector 106 can be attached.



FIG. 2 is a cross-sectional view of the liquid-transfer system of FIG. 1 taken along line II-II. As shown, the injector 106 includes a distal housing 107 and a proximal housing 109. The proximal housing 109 includes a trigger mechanism 111 and a button 113 for firing the injector 106. The distal housing 107 includes a ram 115 and an energy source 117 (e.g., a firing spring) associated therewith to provide energy for firing the injector 106. A firing stopper 119 may be attached to the proximal end of the ram 115 to force out fluid medicament through a jet nozzle 121 when the injector 106 is fired. Additionally, the firing stopper 119 moves proximally to draw liquid 103 from the vial 102 into a cartridge 123. A seal 132 interfaces the jet nozzle 121 and is generally located between the adapter and the distal end of the injector 106. The seal 132 may be provided maintain liquid within the channel and an injector coupled to the adapter 104.



FIG. 3 is an enlarged view of a portion of FIG. 2 showing the vial 102 and the adapter 104. The vial 102 preferably has a neck 125 and a lip 114 that protrudes radially beyond a recessed portion of the neck 127 which may be used to engage the vial 102 with the liquid-transfer adapter 104. Fingers 116 of the adapter can be provided to seat on and engage the lip 114 to hold the vial 102 in an engaged position with respect to the adapter 104. The fingers 116 may be arranged around the spike 118 and extending theretowards for snapping to and retaining the adapter 104 engaged to the vial 102.


The engagement of the vial 102 with the adapter 104 causes a spike 118 of the adapter 104 to puncture a septum (or stopper) 120 of the vial. The spike 118 may be a multifaceted spike having a tip 122 that is preferably axially centered with respect to the central axis of the spike 118. In such embodiments, the tip 122 can have a coaxial point, but in alternative embodiments, the tip and point can be provided off center. One or more facets 124 may include a channel opening 126. Some or all of the channel openings 126 extend on the facet 124 and onto the sidewall 128 of the shaft 129 of the spike 118. As the spike, 118 is pushed through the septum 120, the septum is deformed (as shown at 117) as the sidewall 128 of the shaft 129 pull on the septum. Preferably, the channel openings 126 extend down the sidewall 128 of the shaft 129 so that when the spike 118 is inserted through the septum 120 at least a portion of the channel openings are not exposed outside of the septum. The channel openings 126 are fluidly connected to an interior channel 130 that extends longitudinally through the spike 118 thereof. The openings 126 are generally spaced circumferentially from the edges. Further, the lateral edges of the openings 126 are radially positioned inwardly from the edges at any axial station. The channel 130 provides liquid communication between the vial engaging end 110 and the injector engaging end 112 of the adapter 104.



FIGS. 2 and 3 also show a seal 132, such as a rubber seal or elastomeric septum, which is positioned within the injector engaging end 112 over a terminal end of the channel 130 and configured to prevent fluid from leaking from the interface between the injector engaging end 112 and the injector 106 that is coupled therewith. The seal 132 includes an opening 133 to fluidly communicate the channel 130 to the injector 106. The seal 132 includes a domed region 135 that corresponds with a dome cutaway 137 in the adapter 102 and which helps to achieve a seal. Preferably, the jet nozzle 121 slightly deforms the seal 132 when the two are interfaced.



FIG. 4 illustrates the vial 102 before it is sealed with the stopper 132. The vial 102 has the recessed neck portion 127 and the lip 114. Medicament may be inserted into the vial 102 prior to placing the stopper within the neck 125 of the vial. The stopper 132 may include a generally cylindrical member 145 that is configured to extend into the neck 125 of the vial. Before sealing the vial 102, the stopper 132 may be partially inserted into the vial and medicament may be inserted through a gap 147 of the cylindrical member 145. The gap 147 may take the form of a shortened portion of the cylindrical member 145. The medicament may be placed in the vial in a liquid or a solid form. Additionally, in some embodiments, a liquid medicament inserted into the vial 102 may be heated or otherwise treated so as to be solid before fully inserting the stopper 132. Once the stopper 132 is fully inserted into the vial 102, a cap 149 (e.g., a metal cap) is positioned over the stopper and may subsequently be crimped about the lip 114 of the vial to secure the stopper and seal the vial. The cap 149 may have a removable tab 153 that may be removed for insertion of a spike, such as the spike 118 of the adapter 104. The stopper 132 may have a circular protrusion 151 on its top that may serve to provide a target for the spike. The removable tab 153 may be generally centered over this protrusion 151 in some embodiments so that when it is removed the protrusion is exposed. It should be appreciated that the stopper 132 and/or vial 102 may be provided in a variety of different sizes and/or dimensions.



FIGS. 6-8 show the cross-sectional views of the adapter 104 with the vial 102 with the stoppers in each having different dimensions. Specifically, FIG. 6 illustrates a Ferring 20 mm stopper 155, FIG. 7 illustrates a Teva 20 mm stopper 157, and FIG. 8 illustrates a Ferring 13 mm stopper 159. Each of the stoppers 155, 157 and 159 has a gap 161, 163, and 165. The spike 118 can have the same dimensions in adapters sized for use with different vials, such as in each of the adapters in FIGS. 6-8. This can allow a common mold may be used for the spike 118 that is functional in a variety of adapters and with a variety of vial and stopper sizes. As such, molds for the other parts of the adapter 104 may vary but only a single mold need be designed and prepared for the spike 118 in this embodiment, thus providing manufacturing efficiency and savings.


As may be seen in FIGS. 6-8, channels 126 of the spike preferably extend onto the sidewall 128 from the facets 124 to a distance from the tip that is sufficient so that a portion of the channel 126 is submerged within the septum 120. It should be appreciated, that there is some deformation of the center portions 155, 157, 159 of the septums 120 when the spike is pushed through, as shown in FIG. 3 at 117. The deformation is not shown in FIG. 6-8. However, generally, the channel 126 of the spike 118 terminates at some point within the center portions 155, 157,159 of the septums 120 so that when the coupled vial, adapter, and injector are inverted with the vial on top, the amount of fluid that can be withdrawn from the vial is maximized compared to having the channel openings 126 terminate outside of the septum 120. In an alternative embodiment, however, some or all of the channel openings 126 can be shorter so as to remain spaced from the septum 120 when the spike is fully inserted therein.


It should be appreciated that the extent to which a portion of the aperture remains within the septum 120 and/or the extent to which the end 140 of the channel 126 extends beyond the septum may depend on several factors such as the thickness of the septum, the length of the channel and/or the extent to which the channels extend down the sidewall of the spike. It should be appreciated, however, that preferably the dimensions of the spike 118 are such that they function as intended for a variety of different dimensioned septums/stoppers and/or vials. As such, the tooling for the spike 118 can be reused. The adapter 104 dimensions may vary to accommodate the different sizes of vial necks, for instance. In other embodiments, the dimensions of the spike may vary and tooling may be created to accommodate various spike sizing/dimensions.



FIG. 9 is a perspective view of the liquid-transfer adapter 104 without a vial. The vial engaging end 110 includes a collar 150 that couples to a center body 152 of the adapter with support structures 154. The center body 152 preferably includes a wall 171 that divides the vial and injector engaging ends from each other, and the spike 118 preferably extends from the center body 152. The collar 150 is held by the support structures 152 at a distance from the center body 152 greater than the length of the spike 118. Fingers 116 are distributed about the collar 150 and extend inwardly from the collar 150 towards the spike 118. The fingers 116 may be reflexed so as to snap to the vial and retain the adapter engaged to the vial. Other embodiments may use different mechanisms to engage the adapter to the vial.


Engagement slots 170 on the injector engaging end 112 having engagement members 174 are also shown in FIG. 9. Generally, the engagement slots 170 may be configured to releasably receive and engage flanges of an injector or an adapter. Engagement members 174 may generally be resilient protrusions into the slots 170 configured to hold the flanges and the injector or adapter in a coupled position relative to the adapter 104.



FIG. 10 is an enlarged cross-sectional view of the liquid-transfer adapter 104 of FIG. 9 taken along line X-X. While particular dimensions of the adapter 104 may vary, some example dimensions are provided herein to give a sense of the scale for a preferred adapter. For example, the distance from an outer edge 160 of the collar 150 to the end of the fingers 116 may be, for example, up to around a half of an inch but preferably between about 0.1-0.4 inches, and in one embodiment about a quarter inch. A plurality of fingers 116 may be provided, such as four fingers 116 provided in pairs 180, and configured with a desired stiffness for coupling with the vial. A length of the injector engaging end 112 is typically between about half an inch to an inch or greater, and in one embodiment is approximately 0.8 inches. Additionally, the diameter of the injector engaging end may be up to or greater than about one inch and preferably between 0.4-0.7 inches, for example about half an inch, and in one embodiment about 0.6 inches.


The tip 122 of the spike is shown as axially centered with the spike 118, although in other embodiments the spike may not be axially centered (e.g., may be offset from the center). Generally, the beveled facets 124 may have and angle θ relative to the axis of the spike 118 that is suitable for injection through skin. For example, the angle θ may be up to about 45 degrees relative to the axis of the spike 118 and typically between about 10-20 degrees, or approximately 15 degrees in an embodiment. The beveled facets 124 may have a length A between 0.1-0.17 inches and in one embodiment 0.14 inches longitudinally along the spike 118. A length B along the shaft of the spike from the bevel to a curved portion of the base 162 may be between 0.21-0.26 inches and in one embodiment may be 0.24 inches. The curved portion of the base J may be between 0.01-0.03 inches and in one embodiment approximately 0.02 inches. A length C along the shaft of the spike 118 that includes the curved base 162 may be between 0.22-0.27 inches and may be 0.25 inches in one embodiment. As such, the ratios A/B and A/C may each be between approximately ⅓ to ¾.


The spike 118 may generally have a length D of up to or greater than about half of an inch or longer, and is preferably between about 0.3 and 0.5 inches, and in one embodiment is approximately 0.4 inches. The ratio of A/D may be between ⅕ to ⅔. The spike 118 may have a width E, typically, of about 0.05 to 0.2 inches, preferably between 0.07-0.1 inches, and in one embodiment about 0.08 inches. The width E of the shaft may be slightly larger at a base 162 of the shaft 178. The channel 130 extends through the center of the spike 118 and may have a diameter F that may be between about 0.03-0.06 inches, and in one embodiment is about 0.04 or 0.05 inches and tapers proximally downward. The downward taper may begin where an overlap occurs between the channel 130 and the opening 126. The channel 130 may have a length between 0.1-0.2 inches from the base 162 of the shaft 178 to where the overlap occurs. The overlap of the channel and channel overlap may have a length between 0.08-0.1 inches. The channel 130 may have a depth H between 0.02 and 0.03 inches, and in one embodiment may be approximately 0.025 inches. A ratio H/E may be between approximately ¼ and ⅓. A longitudinal distance I from the tip 122 to the channel opening may be between 0.06 and 0.08 inches, and in one embodiment may be 0.07 inches. A ratio A/I may be between approximately two and ¾.



FIG. 11 illustrates the spike tip 122 as having three facets or bevels that converge to a point 122. The facets 124 meet at edges 190 and channel openings 126 are located within the facets but do not interrupt the edges. The channel openings 126 may generally have a width J between 0.01-0.02 inches, and preferably approximately 0.015 inches, while the facets 124 may generally each have an arcuate length between edges of approximately 0.06 and 0.1 inches, and preferably about 0.08 inches. A ratio of J/K may be between 1/10 and ⅓.


The channel openings 126 are preferably generally centered within the facets 124 so that they do not extend to the junctions of the facets. Thus, the lateral edges of the openings 126 are disposed radially inward compared to the edges 190 and are spaced circumferentially from the edges. This is true at any axial station. As such a radius R1 measured radially from the axis to the openings 126 is less than a radius R2 from the axis to the edge 190. The openings 126 in this embodiment are about 120 degrees apart on center, seen in an axial direction, since they are preferably about equally spaced and centered on the facets 124. The facets 124 may be spaced about the tip of the spike 118 in any suitable manner. In some embodiments, the each facet is the same size as the others, while in other embodiments one or more facets may be differently sized from the others. In an example, one or more facet 124 may have a width less than a tenth of an inch where it meets the sidewall 128 of the shaft. In one embodiment, the channel openings 126 may be up to about 30 degrees wide, measured on a radial plane, about the center and preferably between 5-30 degrees wide (e.g., about 20 degrees wide in one embodiment). A distance G between the tip 122 and the channel openings 126 may be between 0.01-0.02 inches (e.g., 0.015 inches). The channel openings 126 are preferably tapered along the facets 124, but alternatively can have a substantially constant width.


It should be appreciated that the dimensions provided herein are merely exemplary and are not limiting. Indeed, in some embodiments the dimensions may be altered to accommodate certain functionality and/or to couple with injectors and/or vials having different dimensions.


As illustrated in FIG. 12, a cap 220 can be provided that covers the injector engaging end 112 of the adapter 104 prior to use to help keep the adapter sterile. The cap 220 is removable to allow for coupling an injector to with the adaptor 200. FIG. 13 is a cross sectional view taken along ling XIV in FIG. 12. As illustrated, an insert 230 is positioned within the injector engaging end 112 of the adapter 104. The insert 230 is configured to allow for injectors of differing sizes to be coupled and engaged to the adapter 104. In some embodiments, for example, the interior dimensions of the injector engaging end 112 of the adapter 104 may be configured to receive, and generally may correspond in size to, a preselected jet injector type. The insert 230 may be removed for use of the adapter 104 with the jet injector. With the insert 230 in place, the insert can provide dimensions selected for receiving a syringe for reconstituting medicament. Generally, the insert 230 may include flanges 232 that may be inserted into engagement slots 170 of the adapter 104 to secure the insert relative to the adapter. These same slots 170 may be used for engaging a jet injector in place as it is being loaded (i.e., as it extracts liquid from a vial).



FIGS. 14-17 illustrate a process for reconstituting medicament using a syringe 240. In FIG. 14 each of the vial 102, the adapter 104 and the syringe 240 are shown as initially being separate from each other. The adapter 104 may be moved downward to engage the vial 102. In FIG. 15, the cap 220 is removed from the adapter 104 and a cap 242 is removed from the syringe 240. The syringe 240 engages the adapter 104 by entering the injector engaging end 112 of the adapter. Once the syringe 240 and the adapter 104 are joined together, a plunger 244 of the syringe 240 may be depressed to insert liquid into the vial, as shown in FIG. 16. Once the liquid from the syringe has been inserted into the vial 102, the syringe 240 may be removed from the adapter 104. As illustrated in FIG. 17, when the syringe is withdrawn from the injector engaging end 112 of the adapter 104, the insert 230 may be extracted from the adapter as well.


The facets 204 meet at a tip 210 and each facet joins with adjacent facets to form edges 212. The tip 210 is axially centered with respect to the spike 202. The edges 212 at the junction of the facets 204 may be used to cut through a rubber septum or stopper of a vial. Hence, the edges 212 are cutting edges. Furthermore, the apertures 206 are positioned between the edges 212 but do not interfere or disrupt the edges. As such, the edges 212 are disposed more radially outward than the interior portions of the facets 204 where the apertures 206 are positioned. The outward position of the edges 212 localizes the strain concentrations of the septum thereon and away from the apertures 206 as the spike 202 penetrates it.



FIGS. 18-20 are images of the spike 118 penetrating the rubber stopper132 of the vial 102, for example when the adapter 104 is engaging the vial. In particular, FIG. 18 shows the spike 118 from outside the vial 102. The multiple facets 124 may be seen as having channel openings 126 that extend on the sidewall 128 of the shaft 129 of the spike 118. Additionally, the metal collar 149 may be seen. The tab of the metal collar has been removed to allow the spike access to the stopper 132 and remnants 261 of where the tab was connected to the collar 149 remain. The protrusion 151 of the stopper is also shown and serves as a target for the spike 118. The edges 190 at the junction between facets 124 serve as cutting edges as the spike 118 punctures the stopper 132.



FIG. 19 shows a view from within the vial as the spike 118 is pushed through the stopper 132. In some embodiments, tearing of the stopper 132 may occur upon insertion of the spike 118. The edges 190 are preferably sufficiently sharp to provide cutting through the elastomeric stopper 132 to facilitate penetration of the spike 118 therein. As the edges 190 extend radially further than the facet's 124 surfaces the pressure from the stopper 132 is concentrated at the edges. More specifically, stress concentrations from cutting, stretching, and/or tearing of the stopper are localized away from the openings 126 and instead are focused at the points 258 where the edges 190 are contacting the stopper. Thus, the channel openings 126 generally do not provide edges or points for cutting the stopper. This can help avoid coring of the stopper and minimize intrusion of the stopper into the openings 126. Preferably, the stopper 132 material will be pulled away from the channels 126 by the edges 190, and the stopper material that expands into the openings is minimized, such as at 259.



FIG. 20 shows the spike 118 fully inserted into the vial 102. As may be seen, the edges 190 are cleared from the stopper 132 and the channel openings 126 are exposed. Although not shown here, as the spike 118 is pushed through the stopper 132, the stopper is deflected slighted into the vial 132. As such, in a preferred embodiment, the distal end of the channel openings 126 are either flush with the stopper 132 or remain within the stopper so that substantially all of the liquid within the vial may be extracted into an injector, as discussed above.



FIG. 21 is a perspective view of another embodiment of a liquid-transfer adapter 200, which has a spike 202 with four facets 204. Each facet 204 may be similarly or differently sized, and preferably has a channel opening 206 that extends from within the face of the facet and onto the sidewall 208 of the spike 202. The opening 206 is in communication with a channel (not shown) within the spike 202 to provide liquid communication between two ends of the adapter 200.


All of the references specifically identified in the detailed description section of the present application are expressly incorporated herein in their entirety by reference thereto. The term “about,” as used herein, should generally be understood to refer to both the corresponding number and a range of numbers. Moreover, all numerical ranges herein should be understood to include each whole integer within the range, and other embodiments can have other dimensions. Accordingly, the specific embodiments described herein should be understood as examples and not limiting the scope thereof.


While illustrative embodiments of the disclosure are disclosed herein, it will be appreciated that numerous modifications and other embodiments may be devised by those skilled in the art. For example, the features for the various embodiments can be used in other embodiments. Therefore, it will be understood that the appended claims are intended to cover all such modifications and embodiments that come within the spirit and scope of the present disclosure.

Claims
  • 1. A liquid-transfer adapter operatively interposable between an injector and a vial, comprising: an injector engaging portion configured for fluidly coupling to the injector;a vial coupling including a spike that has a spike axis and a tip portion configured for piercing a septum of the vial, the tip portion including plurality of facets that meet each other at one or more edges, at least one of the one or more edges being sloped with respect to the spike axis, the spike defining a channel extending therethrough in fluid communication with the injector engaging portion and including a channel opening defined in at least one of the facets and disposed without interrupting the edges;a body adjacent the injector engaging portion, the spike extending from the body;a collar coupled to the body by a support structure such that the collar is spaced from the body by a distance that is greater than a length of the spike, the collar comprising a continuous circumferential collar; andfingers having a proximal end and a distal end, the distal end coupled to the collar and extending inwardly and proximally toward the injector engaging portion, the fingers configured to couple the liquid-transfer adapter to the vial, wherein the proximal end comprises a free end.
  • 2. The liquid-transfer adapter of claim 1, wherein the edges comprise junctions between the facets.
  • 3. The liquid-transfer adapter of claim 1, wherein the edges comprise cutting surfaces configured for cutting the septum as the spike is pushed therethrough.
  • 4. The liquid-transfer adapter of claim 1, wherein the tip portion comprises at least three facets.
  • 5. The liquid-transfer adapter of claim 4, wherein the channel opening comprises a channel opening disposed in each of at least three of the facets.
  • 6. The liquid-transfer adapter of claim 1 further comprising a seal disposed at the injector engaging portion configured for mating with the injector for maintaining liquid within the channel and injector.
  • 7. The liquid-transfer adapter of claim 1, wherein the fingers comprise reflexed fingers configured for snapping to and retaining the liquid-transfer adapter engaged to the vial.
  • 8. The liquid-transfer adapter of claim 1, wherein the channel openings are spaced circumferentially from the edges.
  • 9. The liquid-transfer adapter of claim 1, wherein lateral edges of the channel openings are disposed radially inward compared to the edges.
  • 10. The liquid-transfer adapter of claim 1, wherein lateral edges of the channel openings are disposed radially inward relative to the edges at any axial position.
  • 11. The liquid-transfer adapter of claim 1, wherein the lateral edges of the channel openings are spaced from the edges sufficiently to minimize intrusion of the septum into the channel openings when the spike is pierced through the septum.
  • 12. The liquid-transfer adapter of claim 1, wherein the channel openings are substantially centered circumferentially on the facets.
  • 13. The liquid-transfer adapter of claim 1, wherein the injector engaging portion comprises dimensions suitable for coupling with a needle free injector.
  • 14. The liquid-transfer adapter of claim 13, wherein a removable insert is removably coupled within the injector engaging portion for selectively configuring the injector engaging portion for engaging variously sized injectors.
  • 15. The liquid-transfer adapter of claim 14, wherein the removable insert comprises dimensions suitable for coupling with a syringe having a first width, and with the insert removed, the injector engaging portion is configured for coupling to a jet injector having a second width that is larger than the first width.
  • 16. The liquid-transfer adapter of claim 1, wherein: the spike comprises a shaft including a sidewall, the shaft extending from the tip towards the injector engaging portion; andthe channel opening extends onto the sidewall of the shaft.
  • 17. The liquid-transfer adapter of claim 1, wherein the edges meet at a point that is substantially axially centered.
  • 18. The liquid-transfer adapter of claim 1, wherein the facets are substantially flat bevels.
  • 19. The liquid transfer adapter of claim 1, wherein the support structure is one of a plurality of support structures, each of the plurality of support structures circumferentially spaced from another of the plurality of support structures.
  • 20. The liquid transfer adapter of claim 1, wherein the fingers are configured to engage a lip of the vial.
  • 21. The liquid transfer adapter of claim 16, wherein the channel opening is configured such that at least a portion of the channel opening is within the septum of the vial when the vial coupling is coupled to the vial.
  • 22. A liquid-transfer adapter operatively interposable between an injector and a vial, comprising: an injector engaging portion configured for fluidly coupling to the injector;a vial coupling including a spike that has a spike axis and a tip portion configured for piercing a septum of the vial, the tip portion including a plurality of facets that meet each other at one or more edges, at least one of the one or more edges being sloped with respect to the spike axis, the spike defining a channel extending therethrough in fluid communication with the injector engaging and including a channel opening defined in at least one of the facets, wherein the channel openings are spaced circumferentially from the edges;a body adjacent the injector engaging portion, the spike extending from the body;a collar coupled to the body by a support structure such that the collar is spaced from the body by a distance that is greater than a length of the spike, wherein the collar comprises a continuous circumferential collar; andfingers having a proximal end and a distal end, the distal end coupled to the collar and extending inwardly and proximally toward the injector engaging portion, the fingers configured to couple the liquid-transfer adapter to the vial, wherein the proximal end comprises a free end.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 13/184,211, entitled “Liquid-Transfer Adapter Beveled Spike,” filed on Jul. 15, 2011, the entire content of which is incorporated herein by reference.

US Referenced Citations (660)
Number Name Date Kind
547370 Chalefou Oct 1895 A
1465793 Schilling Aug 1923 A
1512294 Marcy Oct 1924 A
1687323 Cook Oct 1928 A
2354649 Bruckner Aug 1944 A
2607344 Brown Aug 1952 A
2645223 Lawshe Jul 1953 A
2648334 Brown Aug 1953 A
2687730 Hein Aug 1954 A
2688967 Huber Sep 1954 A
2699166 Bickinson Jan 1955 A
2717601 Brown Sep 1955 A
2728341 Roehr Dec 1955 A
2737946 Hein, Jr. Mar 1956 A
2813528 Blackman Nov 1957 A
2866458 Mesa et al. Dec 1958 A
2888924 Dunmire Jun 1959 A
2893390 Lockhart Jul 1959 A
3130724 Higgins Apr 1964 A
3166069 Enstrom Jan 1965 A
3375825 Keller Apr 1968 A
3382865 Worrall May 1968 A
3526225 Hayamamachi Sep 1970 A
3557784 Shields Jan 1971 A
3563098 Gley Feb 1971 A
3605744 Dwyer Sep 1971 A
3688765 Gasaway Sep 1972 A
3702609 Steiner Nov 1972 A
3712301 Sarnoff Jan 1973 A
3742948 Post et al. Jul 1973 A
3770026 Isenberg Nov 1973 A
3790048 Luciano et al. Feb 1974 A
3797489 Sarnoff Mar 1974 A
3797491 Hurschman Mar 1974 A
3811441 Sarnoff May 1974 A
3831814 Butler Aug 1974 A
3848593 Baldwin Nov 1974 A
3882863 Sarnoff et al. May 1975 A
3892237 Steiner Jul 1975 A
3895633 Bartner et al. Jul 1975 A
3946732 Hurscham Mar 1976 A
4031893 Kaplan et al. Jun 1977 A
4067333 Reinhardt et al. Jan 1978 A
4127118 Latorre Nov 1978 A
4171698 Genese Oct 1979 A
4222392 Brennan Sep 1980 A
4227528 Wardlaw Oct 1980 A
4258713 Wardlaw Mar 1981 A
4282986 af Ekenstam et al. Aug 1981 A
4316463 Schmitz et al. Feb 1982 A
4316643 Burk et al. Feb 1982 A
4328802 Curley et al. May 1982 A
4333456 Webb Jun 1982 A
4333458 Margulies et al. Jun 1982 A
4338980 Schwebel et al. Jul 1982 A
4373526 Kling Feb 1983 A
4378015 Wardlaw Mar 1983 A
4411661 Kersten Oct 1983 A
4484910 Sarnoff et al. Nov 1984 A
4529403 Kamstra Jul 1985 A
4553962 Brunet Nov 1985 A
4558690 Joyce Dec 1985 A
4573971 Kamstra Mar 1986 A
4592745 Rex et al. Jun 1986 A
4624660 Mijers et al. Nov 1986 A
4634027 Kanarvogel Jan 1987 A
4661098 Bekkering et al. Apr 1987 A
4662878 Lindmayer May 1987 A
4664653 Sagstetter et al. May 1987 A
4664655 Orentreich et al. May 1987 A
4678461 Mesa Jul 1987 A
4719825 LaHaye et al. Jan 1988 A
4722728 Dixon Feb 1988 A
4774772 Vetter et al. Oct 1988 A
4790824 Morrow et al. Dec 1988 A
4818517 Kwee et al. Apr 1989 A
4820286 van der Wal Apr 1989 A
4822340 Kamstra Apr 1989 A
4830217 Dufresne et al. May 1989 A
4874381 Vetter Oct 1989 A
4883472 Michel Nov 1989 A
4913699 Parsons Apr 1990 A
4915701 Halkyard Apr 1990 A
4929238 Baum May 1990 A
4936833 Sams Jun 1990 A
4940460 Casey et al. Jul 1990 A
4966581 Landau Oct 1990 A
4968302 Schluter et al. Nov 1990 A
4973318 Holm et al. Nov 1990 A
4976701 Ejlersen et al. Dec 1990 A
4982769 Fournier et al. Jan 1991 A
4986816 Steiner et al. Jan 1991 A
5042977 Bechtold et al. Aug 1991 A
5062830 Dunlap Nov 1991 A
5064413 McKinnon et al. Nov 1991 A
5069670 Vetter et al. Dec 1991 A
5078680 Sarnoff Jan 1992 A
5080648 D'Antonio Jan 1992 A
5080649 Vetter Jan 1992 A
5085641 Sarnoff et al. Feb 1992 A
5085642 Sarnoff et al. Feb 1992 A
5092842 Bechtold et al. Mar 1992 A
5102388 Richmond Apr 1992 A
5102393 Sarnoff et al. Apr 1992 A
5104380 Holman et al. Apr 1992 A
5114406 Gabriel et al. May 1992 A
5137516 Rand et al. Aug 1992 A
5137528 Crose Aug 1992 A
5139490 Vetter et al. Aug 1992 A
5163907 Szuszkiewicz Nov 1992 A
5176643 Kramer et al. Jan 1993 A
5180370 Gillespie Jan 1993 A
5185985 Vetter et al. Feb 1993 A
5195983 Boese Mar 1993 A
5221348 Masano Jun 1993 A
5226895 Harris Jul 1993 A
5232459 Hjertman Aug 1993 A
5256142 Colavecchio Oct 1993 A
5263934 Haak Nov 1993 A
5271744 Kramer et al. Dec 1993 A
5279543 Glikfeld et al. Jan 1994 A
5279576 Loo et al. Jan 1994 A
5279585 Balkwill Jan 1994 A
5279586 Balkwill Jan 1994 A
5281198 Haber et al. Jan 1994 A
5290228 Uemura et al. Mar 1994 A
5295965 Wilmot Mar 1994 A
5300030 Crossman et al. Apr 1994 A
5304128 Haber et al. Apr 1994 A
5304152 Sams Apr 1994 A
5308341 Chanoch May 1994 A
5318522 D'Antonio Jun 1994 A
5320603 Vetter et al. Jun 1994 A
5330431 Herskowitz Jul 1994 A
5332399 Grabenkort et al. Jul 1994 A
5334144 Alchas et al. Aug 1994 A
5342308 Boschetti Aug 1994 A
5350367 Stiehl et al. Sep 1994 A
5354286 Mesa et al. Oct 1994 A
5358489 Wyrick Oct 1994 A
RE34845 Vetter et al. Jan 1995 E
5391151 Wilmot Feb 1995 A
5405362 Kramer et al. Apr 1995 A
5415648 Malay et al. May 1995 A
5425715 Dalling et al. Jun 1995 A
5451210 Krammer et al. Sep 1995 A
5478316 Bitdinger et al. Dec 1995 A
5505694 Hubbard et al. Apr 1996 A
5514097 Knauer May 1996 A
5514107 Haber et al. May 1996 A
5540664 Wyrick Jul 1996 A
5542760 Chanoch et al. Aug 1996 A
5544234 Terajima et al. Aug 1996 A
5549561 Hjertman Aug 1996 A
5554134 Bonnichsen Sep 1996 A
5562625 Stefancin, Jr. Oct 1996 A
5567160 Massino Oct 1996 A
5569190 D'Antonio Oct 1996 A
5569192 van der Wal Oct 1996 A
5569236 Kriesel Oct 1996 A
5573042 De Haen Nov 1996 A
5593388 Phillips Jan 1997 A
5599302 Lilley et al. Feb 1997 A
5599309 Marshall et al. Feb 1997 A
5605542 Tanaka et al. Feb 1997 A
5637094 Stewart, Jr. et al. Jun 1997 A
5649912 Peterson Jul 1997 A
5658259 Pearson et al. Aug 1997 A
5665071 Wyrick Sep 1997 A
5688251 Chanoch Nov 1997 A
5695472 Wyrick Dec 1997 A
5704911 Parsons Jan 1998 A
5725508 Chanoch et al. Mar 1998 A
5730723 Castellano et al. Mar 1998 A
5743889 Sams Apr 1998 A
5769138 Sadowski et al. Jun 1998 A
5785691 Vetter et al. Jul 1998 A
5788670 Reinhard et al. Aug 1998 A
5801057 Smart et al. Sep 1998 A
5807309 Lundquist et al. Sep 1998 A
5820602 Kovelman et al. Oct 1998 A
5820622 Gross et al. Oct 1998 A
5827232 Chanoch et al. Oct 1998 A
5836911 Marzynski et al. Nov 1998 A
5839715 Leinsing Nov 1998 A
5843036 Olive et al. Dec 1998 A
5846233 Lilley et al. Dec 1998 A
5851197 Marano et al. Dec 1998 A
5851198 Castellano et al. Dec 1998 A
5860456 Bydlon et al. Jan 1999 A
5865795 Schiff et al. Feb 1999 A
5865799 Tanaka et al. Feb 1999 A
5868711 Kramer et al. Feb 1999 A
5873857 Kriesel Feb 1999 A
5875976 Nelson et al. Mar 1999 A
5879327 DeFarges et al. Mar 1999 A
5891085 Lilley et al. Apr 1999 A
5891086 Weston Apr 1999 A
5893397 Peterson et al. Apr 1999 A
5893842 Imbert Apr 1999 A
5899888 Jepson May 1999 A
5919159 Lilley et al. Jul 1999 A
5921966 Bendek et al. Jul 1999 A
5925017 Kriesel et al. Jul 1999 A
5928205 Marshall Jul 1999 A
5935949 White Aug 1999 A
5951528 Parkin Sep 1999 A
5957897 Jeffrey Sep 1999 A
5960797 Kramer et al. Oct 1999 A
5989227 Vetter et al. Nov 1999 A
6004297 Steenfeldt-Jensen et al. Dec 1999 A
6045534 Jacobson et al. Apr 2000 A
6056716 D'Antonio et al. May 2000 A
6077247 Marshall et al. Jun 2000 A
6083201 Skinkle Jul 2000 A
6090070 Hager et al. Jul 2000 A
6099504 Gross et al. Aug 2000 A
6123684 Deboer et al. Sep 2000 A
6132395 Landau et al. Oct 2000 A
6159181 Crossman et al. Dec 2000 A
6171276 Lippe et al. Jan 2001 B1
6186997 Gabbard Feb 2001 B1
6203529 Gabriel et al. Mar 2001 B1
6210369 Wilmot et al. Apr 2001 B1
6221046 Burroughs et al. Apr 2001 B1
6221053 Walters et al. Apr 2001 B1
6223408 Vetter et al. May 2001 B1
6231540 Smedegaard May 2001 B1
6241709 Bechtold et al. Jun 2001 B1
6245347 Zhang et al. Jun 2001 B1
6258078 Thilly Jul 2001 B1
6264629 Landau Jul 2001 B1
6270479 Bergens et al. Aug 2001 B1
6309371 Deboer et al. Oct 2001 B1
6319224 Stout et al. Nov 2001 B1
6371939 Bergens et al. Apr 2002 B2
6383168 Landau et al. May 2002 B1
6391003 Lesch, Jr. May 2002 B1
6406456 Slate et al. Jun 2002 B1
6428528 Sadowski et al. Aug 2002 B2
6471669 Landau Oct 2002 B2
6494865 Alchas Dec 2002 B1
6517517 Farrugia et al. Feb 2003 B1
6530904 Edwards et al. Mar 2003 B1
6544234 Gabriel Apr 2003 B1
6562006 Hjertman et al. May 2003 B1
6565553 Sadowski et al. May 2003 B2
6568259 Saheki et al. May 2003 B2
6569123 Alchas et al. May 2003 B2
6569143 Alchas et al. May 2003 B2
6584910 Plass Jul 2003 B1
6589210 Rolfe Jul 2003 B1
6607508 Knauer Aug 2003 B2
6620137 Kirchhofer et al. Sep 2003 B2
6641561 Hill et al. Nov 2003 B1
6645170 Landau Nov 2003 B2
6656150 Hill et al. Dec 2003 B2
6673035 Rice et al. Jan 2004 B1
6682504 Nelson et al. Jan 2004 B2
6689092 Zierenberg et al. Feb 2004 B2
6706000 Perez et al. Mar 2004 B2
6746429 Sadowski et al. Jun 2004 B2
6767336 Kaplan Jul 2004 B1
6805686 Fathallah et al. Oct 2004 B1
6830560 Gross et al. Dec 2004 B1
6899698 Sams May 2005 B2
6932793 Marshall et al. Aug 2005 B1
6932794 Giambattista et al. Aug 2005 B2
6936032 Bush, Jr. et al. Aug 2005 B1
6969370 Langley et al. Nov 2005 B2
6969372 Halseth Nov 2005 B1
6979316 Rubin et al. Dec 2005 B1
6986758 Schiffmann Jan 2006 B2
6997901 Popovsky Feb 2006 B2
7018364 Giambattista et al. Mar 2006 B2
7066907 Crossman et al. Jun 2006 B2
7112187 Karlsson Sep 2006 B2
7118552 Shaw et al. Oct 2006 B2
7118553 Scherer Oct 2006 B2
7169132 Bendek et al. Jan 2007 B2
7195616 Diller et al. Mar 2007 B2
7218962 Freyman May 2007 B2
7220247 Shaw et al. May 2007 B2
7247149 Beyerlein Jul 2007 B2
7291132 DeRuntz et al. Nov 2007 B2
7292885 Scott et al. Nov 2007 B2
7297136 Wyrick Nov 2007 B2
7341575 Rice et al. Mar 2008 B2
7361160 Hommann et al. Apr 2008 B2
7390314 Stutz, Jr. et al. Jun 2008 B2
7390319 Friedman Jun 2008 B2
7407492 Gurtner Aug 2008 B2
7416540 Edwards et al. Aug 2008 B2
7442185 Amark et al. Oct 2008 B2
7449012 Young et al. Nov 2008 B2
7488308 Lesch, Jr. Feb 2009 B2
7488313 Segal et al. Feb 2009 B2
7488314 Segal et al. Feb 2009 B2
7500964 Shaw et al. Mar 2009 B2
7517342 Scott et al. Apr 2009 B2
7519418 Scott et al. Apr 2009 B2
7544188 Edwards et al. Jun 2009 B2
7547293 Williamson et al. Jun 2009 B2
7569035 Wilmot et al. Aug 2009 B1
7611491 Pickhard Nov 2009 B2
7621887 Griffiths et al. Nov 2009 B2
7621891 Wyrick Nov 2009 B2
7635348 Raven et al. Dec 2009 B2
7635350 Scherer Dec 2009 B2
7637891 Wall Dec 2009 B2
7648482 Edwards et al. Jan 2010 B2
7648483 Edwards et al. Jan 2010 B2
7654983 De La Sema et al. Feb 2010 B2
7658724 Rubin et al. Feb 2010 B2
7670314 Wall et al. Mar 2010 B2
7704237 Fisher et al. Apr 2010 B2
7717877 Lavi et al. May 2010 B2
7722595 Pettis et al. May 2010 B2
7731686 Edwards et al. Jun 2010 B2
7731690 Edwards et al. Jun 2010 B2
7736333 Gillespie, III Jun 2010 B2
7744582 Sadowski et al. Jun 2010 B2
7749194 Edwards et al. Jul 2010 B2
7749195 Hommann Jul 2010 B2
7762996 Palasis Jul 2010 B2
7776015 Sadowski et al. Aug 2010 B2
7794432 Young et al. Sep 2010 B2
7811254 Wilmot et al. Oct 2010 B2
7862543 Potter et al. Jan 2011 B2
7896841 Wall et al. Mar 2011 B2
7901377 Harrison et al. Mar 2011 B1
7905352 Wyrick Mar 2011 B2
7905866 Haider et al. Mar 2011 B2
7918823 Edwards et al. Apr 2011 B2
7927303 Wyrick Apr 2011 B2
7931618 Wyrick Apr 2011 B2
7947017 Edwards et al. May 2011 B2
RE42463 Landau Jun 2011 E
7955304 Guillermo Jun 2011 B2
7967772 McKenzie et al. Jun 2011 B2
7988675 Gillespie, III et al. Aug 2011 B2
8016774 Freeman et al. Sep 2011 B2
8016788 Edwards et al. Sep 2011 B2
8021335 Lesch, Jr. Sep 2011 B2
8048035 Mesa et al. Nov 2011 B2
8048037 Kohlbrenner et al. Nov 2011 B2
8057427 Griffiths et al. Nov 2011 B2
8066659 Joshi et al. Nov 2011 B2
8083711 Enggaard Dec 2011 B2
8100865 Spofforth Jan 2012 B2
8105272 Williamson et al. Jan 2012 B2
8105281 Edwards et al. Jan 2012 B2
8110209 Prestrelski et al. Feb 2012 B2
8123719 Edwards et al. Feb 2012 B2
8123724 Gillespie, III Feb 2012 B2
8162873 Muto et al. Apr 2012 B2
8162886 Sadowski et al. Apr 2012 B2
8167840 Matusch May 2012 B2
8167866 Klein May 2012 B2
8177758 Brooks, Jr. et al. May 2012 B2
8187224 Wyrick May 2012 B2
8216180 Tschirren et al. Jul 2012 B2
8216192 Burroughs et al. Jul 2012 B2
8226618 Geertsen Jul 2012 B2
8226631 Boyd et al. Jul 2012 B2
8233135 Jansen et al. Jul 2012 B2
8235952 Wikner Aug 2012 B2
8246577 Schrul et al. Aug 2012 B2
8251947 Kramer et al. Aug 2012 B2
8257318 Thogersen et al. Sep 2012 B2
8257319 Plumptre Sep 2012 B2
8267899 Moller Sep 2012 B2
8267900 Harms et al. Sep 2012 B2
8273798 Bausch et al. Sep 2012 B2
8275454 Adachi et al. Sep 2012 B2
8276583 Farieta et al. Oct 2012 B2
8277412 Kronestedt Oct 2012 B2
8277413 Kirchhofer Oct 2012 B2
8298175 Hirschel et al. Oct 2012 B2
8298194 Moller Oct 2012 B2
8300852 Terada Oct 2012 B2
RE43834 Steenfeldt-Jensen et al. Nov 2012 E
8308232 Zamperla et al. Nov 2012 B2
8308695 Laiosa Nov 2012 B2
8313466 Edwards et al. Nov 2012 B2
8317757 Plumptre Nov 2012 B2
8323237 Radmer et al. Dec 2012 B2
8333739 Moller Dec 2012 B2
8337472 Edginton et al. Dec 2012 B2
8343103 Moser Jan 2013 B2
8343109 Marshall et al. Jan 2013 B2
8348905 Radmer et al. Jan 2013 B2
8353878 Moller et al. Jan 2013 B2
8357120 Moller et al. Jan 2013 B2
8357125 Grunhut et al. Jan 2013 B2
8361036 Moller et al. Jan 2013 B2
8366680 Raab Feb 2013 B2
8372031 Elmen et al. Feb 2013 B2
8372042 Wieselblad Feb 2013 B2
8376993 Cox et al. Feb 2013 B2
8398593 Eich et al. Mar 2013 B2
8409149 Hommann et al. Apr 2013 B2
8435215 Arby et al. May 2013 B2
20010039394 Weston Nov 2001 A1
20010049496 Kirchhofer et al. Dec 2001 A1
20020007149 Nelson et al. Jan 2002 A1
20020045866 Sadowski et al. Apr 2002 A1
20020173752 Polzin Nov 2002 A1
20020183690 Amisolle Dec 2002 A1
20020188251 Staylor et al. Dec 2002 A1
20030040697 Pass et al. Feb 2003 A1
20030083621 Shaw et al. May 2003 A1
20030105430 Lavi et al. Jun 2003 A1
20030130619 Safabash et al. Jul 2003 A1
20030158523 Hjertman et al. Aug 2003 A1
20030171717 Farrugia et al. Sep 2003 A1
20030229330 Hickle Dec 2003 A1
20030236502 De La Serna et al. Dec 2003 A1
20040039336 Amark et al. Feb 2004 A1
20040039337 Letzing Feb 2004 A1
20040097783 Peters et al. May 2004 A1
20040097883 Roe May 2004 A1
20040143213 Hunter et al. Jul 2004 A1
20040220524 Sadowski et al. Nov 2004 A1
20040267207 Veasey et al. Dec 2004 A1
20040267355 Scott et al. Dec 2004 A1
20050020979 Westbye et al. Jan 2005 A1
20050027255 Lavi et al. Feb 2005 A1
20050033234 Sadowski et al. Feb 2005 A1
20050080377 Sadowski et al. Apr 2005 A1
20050101919 Brunnberg May 2005 A1
20050165360 Stamp Jul 2005 A1
20050165363 Judson et al. Jul 2005 A1
20050209569 Ishikawa et al. Sep 2005 A1
20050215955 Slawson Sep 2005 A1
20050240145 Scott et al. Oct 2005 A1
20050256499 Pettis et al. Nov 2005 A1
20050261634 Karlsson Nov 2005 A1
20050273054 Asch Dec 2005 A1
20060025747 Sullivan et al. Feb 2006 A1
20060106362 Pass et al. May 2006 A1
20060129122 Wyrick Jun 2006 A1
20060224124 Scherer Oct 2006 A1
20060258988 Keitel et al. Nov 2006 A1
20060258990 Weber Nov 2006 A1
20070017533 Wyrick Jan 2007 A1
20070025890 Joshi et al. Feb 2007 A1
20070027430 Hommann Feb 2007 A1
20070060904 Vedrine Mar 2007 A1
20070088288 Barron et al. Apr 2007 A1
20070093775 Daly Apr 2007 A1
20070100288 Bozeman et al. May 2007 A1
20070123818 Griffiths et al. May 2007 A1
20070123829 Atterbury et al. May 2007 A1
20070129686 Daily et al. Jun 2007 A1
20070129687 Marshall et al. Jun 2007 A1
20070185432 Etheredge et al. Aug 2007 A1
20070191784 Jacobs et al. Aug 2007 A1
20070219498 Malone et al. Sep 2007 A1
20080059133 Edwards et al. Mar 2008 A1
20080154199 Wyrick Jun 2008 A1
20080154200 Lesch Jun 2008 A1
20080185069 Clark Aug 2008 A1
20080262427 Hommann Oct 2008 A1
20080262436 Olson Oct 2008 A1
20080262445 Hsu et al. Oct 2008 A1
20090036866 Moy Feb 2009 A1
20090124981 Evans May 2009 A1
20090124997 Pettis et al. May 2009 A1
20090204062 Muto et al. Aug 2009 A1
20090216212 Fangrow, Jr. Aug 2009 A1
20090254027 Moller Oct 2009 A1
20090254035 Kohlbrenner et al. Oct 2009 A1
20090292240 Kramer et al. Nov 2009 A1
20090299278 Lesch, Jr. et al. Dec 2009 A1
20090304812 Staniforth et al. Dec 2009 A1
20090312705 Grunhut Dec 2009 A1
20090318361 Noera et al. Dec 2009 A1
20100016326 Will Jan 2010 A1
20100036318 Raday et al. Feb 2010 A1
20100049125 James et al. Feb 2010 A1
20100069845 Marshall et al. Mar 2010 A1
20100076378 Runfola Mar 2010 A1
20100076400 Wall Mar 2010 A1
20100087847 Hong Apr 2010 A1
20100094214 Abry et al. Apr 2010 A1
20100094324 Huang et al. Apr 2010 A1
20100100039 Wyrick Apr 2010 A1
20100114058 Weitzel et al. May 2010 A1
20100121272 Marshall et al. May 2010 A1
20100137798 Streit et al. Jun 2010 A1
20100152699 Ferrari et al. Jun 2010 A1
20100152702 Vigil et al. Jun 2010 A1
20100160894 Julian et al. Jun 2010 A1
20100168677 Gabriel et al. Jul 2010 A1
20100174268 Wilmot et al. Jul 2010 A1
20100191217 Hommann et al. Jul 2010 A1
20100204678 Imran Aug 2010 A1
20100217105 Yodfat et al. Aug 2010 A1
20100228193 Wyrick Sep 2010 A1
20100249746 Klein Sep 2010 A1
20100256570 Maritan Oct 2010 A1
20100258631 Rueblinger et al. Oct 2010 A1
20100262082 Brooks et al. Oct 2010 A1
20100262083 Grunhut et al. Oct 2010 A1
20100268170 Carrel et al. Oct 2010 A1
20100274198 Bechtold Oct 2010 A1
20100274273 Schraga et al. Oct 2010 A1
20100288593 Chiesa et al. Nov 2010 A1
20100292643 Wilmot et al. Nov 2010 A1
20100292653 Maritan Nov 2010 A1
20100298780 Laiosa Nov 2010 A1
20100312196 Hirschel et al. Dec 2010 A1
20100318035 Edwards et al. Dec 2010 A1
20100318037 Young et al. Dec 2010 A1
20100324480 Chun Dec 2010 A1
20110021989 Janet et al. Jan 2011 A1
20110034879 Crow Feb 2011 A1
20110054414 Shang et al. Mar 2011 A1
20110077599 Wozencroft Mar 2011 A1
20110087192 Uhland et al. Apr 2011 A1
20110098655 Jennings et al. Apr 2011 A1
20110098656 Burnell et al. Apr 2011 A1
20110125076 Kraft et al. May 2011 A1
20110125100 Schwirtz et al. May 2011 A1
20110137246 Cali et al. Jun 2011 A1
20110137247 Mesa et al. Jun 2011 A1
20110144594 Sund et al. Jun 2011 A1
20110190725 Pettis et al. Aug 2011 A1
20110196300 Edwards et al. Aug 2011 A1
20110196311 Bicknell et al. Aug 2011 A1
20110224620 Johansen et al. Sep 2011 A1
20110238003 Bruno-Raimondi et al. Sep 2011 A1
20110269750 Kley et al. Nov 2011 A1
20110319864 Beller et al. Dec 2011 A1
20120004608 Lesch, Jr. Jan 2012 A1
20120016296 Cleathero Jan 2012 A1
20120046609 Mesa et al. Feb 2012 A1
20120053563 Du Mar 2012 A1
20120059319 Segal Mar 2012 A1
20120071829 Edwards et al. Mar 2012 A1
20120095443 Ferrari et al. Apr 2012 A1
20120101475 Wilmot et al. Apr 2012 A1
20120116318 Edwards et al. May 2012 A1
20120123350 Giambattista et al. May 2012 A1
20120123385 Edwards et al. May 2012 A1
20120130318 Young May 2012 A1
20120130342 Cleathero May 2012 A1
20120136303 Cleathero May 2012 A1
20120136318 Lanin et al. May 2012 A1
20120143144 Young Jun 2012 A1
20120157931 Nzike Jun 2012 A1
20120157965 Wotton et al. Jun 2012 A1
20120172809 Plumptre Jul 2012 A1
20120172811 Enggaard et al. Jul 2012 A1
20120172812 Plumptre et al. Jul 2012 A1
20120172813 Plumptre et al. Jul 2012 A1
20120172814 Plumptre et al. Jul 2012 A1
20120172815 Holmqvist Jul 2012 A1
20120172816 Boyd et al. Jul 2012 A1
20120172818 Harms et al. Jul 2012 A1
20120172885 Drapeau et al. Jul 2012 A1
20120179100 Sadowski et al. Jul 2012 A1
20120179137 Bartlett et al. Jul 2012 A1
20120184900 Marshall et al. Jul 2012 A1
20120184917 Born et al. Jul 2012 A1
20120184918 Bostrom Jul 2012 A1
20120186075 Edginton Jul 2012 A1
20120191048 Eaton Jul 2012 A1
20120191049 Harms et al. Jul 2012 A1
20120197209 Bicknell et al. Aug 2012 A1
20120197213 Kohlbrenner et al. Aug 2012 A1
20120203184 Selz et al. Aug 2012 A1
20120203185 Kristensen et al. Aug 2012 A1
20120203186 Vogt et al. Aug 2012 A1
20120209192 Alexandersson Aug 2012 A1
20120209200 Jones et al. Aug 2012 A1
20120209210 Plumptre et al. Aug 2012 A1
20120209211 Plumptre et al. Aug 2012 A1
20120209212 Plumptre et al. Aug 2012 A1
20120215162 Nielsen et al. Aug 2012 A1
20120215176 Veasey et al. Aug 2012 A1
20120220929 Nagel et al. Aug 2012 A1
20120220941 Jones Aug 2012 A1
20120220953 Holmqvist Aug 2012 A1
20120220954 Cowe Aug 2012 A1
20120226226 Edwards et al. Sep 2012 A1
20120230620 Holdgate et al. Sep 2012 A1
20120232517 Saiki Sep 2012 A1
20120245516 Tschirren et al. Sep 2012 A1
20120245532 Frantz et al. Sep 2012 A1
20120253274 Karlsson et al. Oct 2012 A1
20120253287 Giambattista et al. Oct 2012 A1
20120253288 Dasbach et al. Oct 2012 A1
20120253289 Cleathero Oct 2012 A1
20120253290 Geertsen Oct 2012 A1
20120253314 Harish et al. Oct 2012 A1
20120259285 Schabbach et al. Oct 2012 A1
20120265153 Jugl et al. Oct 2012 A1
20120267761 Kim et al. Oct 2012 A1
20120271233 Bruggermann et al. Oct 2012 A1
20120271243 Plumptre et al. Oct 2012 A1
20120277724 Larsen et al. Nov 2012 A1
20120283645 Veasey et al. Nov 2012 A1
20120283648 Veasey et al. Nov 2012 A1
20120283649 Veasey et al. Nov 2012 A1
20120283650 MacDonald et al. Nov 2012 A1
20120283651 Veasey et al. Nov 2012 A1
20120283652 MacDonald et al. Nov 2012 A1
20120283654 MacDonald et al. Nov 2012 A1
20120283660 Jones et al. Nov 2012 A1
20120283661 Jugl et al. Nov 2012 A1
20120289907 Veasey et al. Nov 2012 A1
20120289908 Kouyoumjian et al. Nov 2012 A1
20120289909 Raab et al. Nov 2012 A1
20120289929 Boyd et al. Nov 2012 A1
20120291778 Nagel et al. Nov 2012 A1
20120296276 Nicholls et al. Nov 2012 A1
20120296287 Veasey et al. Nov 2012 A1
20120302989 Kramer et al. Nov 2012 A1
20120302992 Brooks et al. Nov 2012 A1
20120310156 Karlsson et al. Dec 2012 A1
20120310206 Kouyoumjian et al. Dec 2012 A1
20120310208 Kirchhofer Dec 2012 A1
20120310289 Bottlang et al. Dec 2012 A1
20120316508 Kirchhofer Dec 2012 A1
20120323177 Adams et al. Dec 2012 A1
20120323186 Karlsen et al. Dec 2012 A1
20120325865 Forstreuter et al. Dec 2012 A1
20120330228 Day et al. Dec 2012 A1
20130006191 Jugl et al. Jan 2013 A1
20130006192 Teucher et al. Jan 2013 A1
20130006193 Veasey et al. Jan 2013 A1
20130006310 Bottlang et al. Jan 2013 A1
20130012871 Pommerau Jan 2013 A1
20130012884 Pommerau et al. Jan 2013 A1
20130012885 Bode et al. Jan 2013 A1
20130018310 Boyd et al. Jan 2013 A1
20130018313 Kramer et al. Jan 2013 A1
20130018317 Bobroff et al. Jan 2013 A1
20130018323 Boyd et al. Jan 2013 A1
20130018327 Dasbach et al. Jan 2013 A1
20130018328 Jugl et al. Jan 2013 A1
20130023830 Bode Jan 2013 A1
20130030367 Wotton et al. Jan 2013 A1
20130030378 Jugl et al. Jan 2013 A1
20130030383 Keitel Jan 2013 A1
20130030409 Macdonald et al. Jan 2013 A1
20130035641 Moller et al. Feb 2013 A1
20130035642 Daniel Feb 2013 A1
20130035644 Giambattista et al. Feb 2013 A1
20130035645 Bicknell et al. Feb 2013 A1
20130035647 Veasey et al. Feb 2013 A1
20130041321 Cross et al. Feb 2013 A1
20130041324 Daniel Feb 2013 A1
20130041325 Helmer et al. Feb 2013 A1
20130041327 Daniel Feb 2013 A1
20130041328 Daniel Feb 2013 A1
20130041347 Daniel Feb 2013 A1
20130060231 Adlon et al. Mar 2013 A1
Foreign Referenced Citations (493)
Number Date Country
00081651 Oct 2012 AR
082053 Nov 2012 AR
2007253481 Nov 2007 AU
2007301890 Apr 2008 AU
2008231897 Oct 2008 AU
2008309660 Apr 2009 AU
2009217376 Oct 2009 AU
2009272992 Jan 2010 AU
2009299888 Apr 2010 AU
2009326132 Aug 2011 AU
2009326321 Aug 2011 AU
2009326322 Aug 2011 AU
2009326323 Aug 2011 AU
2009326324 Aug 2011 AU
2009326325 Aug 2011 AU
2009341040 Sep 2011 AU
2010233924 Nov 2011 AU
2010239762 Dec 2011 AU
2010242096 Dec 2011 AU
2010254627 Jan 2012 AU
2010260568 Feb 2012 AU
2010260569 Feb 2012 AU
2010287033 Apr 2012 AU
2010303987 May 2012 AU
2010332857 Jul 2012 AU
2010332862 Jul 2012 AU
2010337136 Jul 2012 AU
2010338469 Jul 2012 AU
2010314315 Aug 2012 AU
2011212490 Aug 2012 AU
2011212556 Aug 2012 AU
2011212558 Aug 2012 AU
2011212561 Aug 2012 AU
2011212564 Aug 2012 AU
2011212566 Aug 2012 AU
2011212567 Aug 2012 AU
2011214922 Aug 2012 AU
2011221472 Aug 2012 AU
2011231688 Sep 2012 AU
2011231691 Sep 2012 AU
2011224884 Oct 2012 AU
2011231570 Oct 2012 AU
2011231697 Oct 2012 AU
2011233733 Oct 2012 AU
2011234479 Oct 2012 AU
2011238967 Nov 2012 AU
2011244232 Nov 2012 AU
2011244236 Nov 2012 AU
2011244237 Nov 2012 AU
2011249098 Nov 2012 AU
2011262408 Dec 2012 AU
2011270934 Jan 2013 AU
2011273721 Jan 2013 AU
2011273722 Jan 2013 AU
2011273723 Jan 2013 AU
2011273724 Jan 2013 AU
2011273725 Jan 2013 AU
2011273726 Jan 2013 AU
2011273727 Jan 2013 AU
2011273728 Jan 2013 AU
0208013 Mar 2004 BR
0308262 Jan 2005 BR
P1712805 Oct 2012 BR
P10713802-4 Nov 2012 BR
0214721 Dec 2012 BR
2552177 Jul 1999 CA
2689022 Nov 2002 CA
2473371 Jul 2003 CA
2557897 Oct 2005 CA
02702412 Dec 2008 CA
101094700 Dec 2007 CN
101128231 Feb 2008 CN
101184520 May 2008 CN
101400394 Apr 2009 CN
101405582 Apr 2009 CN
101479000 Jul 2009 CN
101511410 Aug 2009 CN
101516421 Aug 2009 CN
101557849 Oct 2009 CN
101563123 Oct 2009 CN
101594898 Dec 2009 CN
101600468 Dec 2009 CN
101605569 Dec 2009 CN
101610804 Dec 2009 CN
101626796 Jan 2010 CN
101678166 Mar 2010 CN
101678172 Mar 2010 CN
101678173 Mar 2010 CN
101687078 Mar 2010 CN
101687079 Mar 2010 CN
101687080 Mar 2010 CN
101715371 May 2010 CN
101909673 Dec 2010 CN
101912650 Dec 2010 CN
101939034 Jan 2011 CN
101939036 Jan 2011 CN
102548599 Jul 2012 CN
102548601 Jul 2012 CN
102548602 Jul 2012 CN
102573955 Jul 2012 CN
102573958 Jul 2012 CN
102573960 Jul 2012 CN
102573963 Jul 2012 CN
102630172 Aug 2012 CN
102630173 Aug 2012 CN
102630174 Aug 2012 CN
102639170 Aug 2012 CN
102639171 Aug 2012 CN
102648014 Aug 2012 CN
102655899 Sep 2012 CN
102665800 Sep 2012 CN
102665802 Sep 2012 CN
102686255 Sep 2012 CN
102686256 Sep 2012 CN
102686258 Sep 2012 CN
102695531 Sep 2012 CN
102695532 Sep 2012 CN
102711878 Oct 2012 CN
102727965 Oct 2012 CN
102740907 Oct 2012 CN
102753222 Oct 2012 CN
102753223 Oct 2012 CN
102753224 Oct 2012 CN
102753227 Oct 2012 CN
101563124 Nov 2012 CN
102770170 Nov 2012 CN
102770173 Nov 2012 CN
102781499 Nov 2012 CN
102781500 Nov 2012 CN
102802699 Nov 2012 CN
102802702 Nov 2012 CN
102802703 Nov 2012 CN
102665801 Dec 2012 CN
102821801 Dec 2012 CN
102821802 Dec 2012 CN
102821805 Dec 2012 CN
102834133 Dec 2012 CN
102869399 Jan 2013 CN
102895718 Jan 2013 CN
102905613 Jan 2013 CN
102905742 Jan 2013 CN
102905743 Jan 2013 CN
102905744 Jan 2013 CN
102905745 Jan 2013 CN
102917738 Feb 2013 CN
102917743 Feb 2013 CN
102006041809 Mar 2008 DE
202011110155 Dec 2012 DE
1646844 Dec 2009 DK
2229201 Jul 2012 DK
2023982 Oct 2012 DK
2274032 Oct 2012 DK
02346552 Nov 2012 DK
1888148 Jan 2013 DK
2288400 Jan 2013 DK
2373361 Jan 2013 DK
1885414 Feb 2013 DK
2174682 Feb 2013 DK
2310073 Feb 2013 DK
25844 Sep 2012 EG
0072057 Feb 1983 EP
0103664 Mar 1984 EP
1752174 Mar 1986 EP
245895 Nov 1987 EP
255044 Feb 1988 EP
361668 Apr 1990 EP
0518416 Dec 1992 EP
525525 Feb 1993 EP
1067823 Jan 2001 EP
1161961 Dec 2001 EP
1307012 May 2003 EP
1518575 Mar 2005 EP
1140260 Aug 2005 EP
1944050 Jul 2008 EP
2174682 Apr 2010 EP
2258424 Dec 2010 EP
2258425 Dec 2010 EP
02275158 Jan 2011 EP
2364742 Sep 2011 EP
2393062 Dec 2011 EP
2471564 Jul 2012 EP
02477681 Jul 2012 EP
02484395 Aug 2012 EP
2526987 Nov 2012 EP
02529773 Dec 2012 EP
02529774 Dec 2012 EP
02529775 Dec 2012 EP
2549789 Jan 2013 EP
02385630 Jul 2012 ES
2389866 Nov 2012 ES
2392667 Dec 2012 ES
02393173 Dec 2012 ES
2394556 Feb 2013 ES
2506161 Nov 1982 FR
2635009 Feb 1990 FR
6677523 Aug 1952 GB
1181037 Feb 1970 GB
1216813 Dec 1970 GB
2463034 Mar 2010 GB
171247 Aug 2012 IL
198750 Oct 2012 IL
HO9290012 Nov 1997 JP
10-507935 Aug 1998 JP
11-347121 Dec 1999 JP
2000-245839 Sep 2000 JP
2001-523485 Nov 2001 JP
2005516696 Jun 2005 JP
5016490 May 2008 JP
5026411 Nov 2008 JP
5033792 Nov 2008 JP
5074397 Feb 2009 JP
2009-529395 Aug 2009 JP
5066177 Sep 2009 JP
5039135 Nov 2009 JP
5044625 Dec 2009 JP
2010-005414 Jan 2010 JP
2010-046507 Mar 2010 JP
2010538744 Dec 2010 JP
4970282 Jul 2012 JP
4970286 Jul 2012 JP
4972147 Jul 2012 JP
4977209 Jul 2012 JP
4977252 Jul 2012 JP
4979686 Jul 2012 JP
4982722 Jul 2012 JP
2012515566 Jul 2012 JP
2012515585 Jul 2012 JP
2012515587 Jul 2012 JP
2012516168 Jul 2012 JP
2012516736 Jul 2012 JP
2012516737 Jul 2012 JP
4990151 Aug 2012 JP
4992147 Aug 2012 JP
4994370 Aug 2012 JP
5001001 Aug 2012 JP
2012143646 Aug 2012 JP
2012148198 Aug 2012 JP
2012519508 Aug 2012 JP
2012519511 Aug 2012 JP
2012519514 Aug 2012 JP
2012176295 Sep 2012 JP
2012183322 Sep 2012 JP
2012520128 Sep 2012 JP
2012521821 Sep 2012 JP
2012521825 Sep 2012 JP
2012521826 Sep 2012 JP
2012521827 Sep 2012 JP
2012521828 Sep 2012 JP
2012521829 Sep 2012 JP
2012521830 Sep 2012 JP
2012521831 Sep 2012 JP
2012521834 Sep 2012 JP
2012522547 Sep 2012 JP
2012-525172 Oct 2012 JP
2012-525180 Oct 2012 JP
2012-525185 Oct 2012 JP
2012523876 Oct 2012 JP
2012525200 Oct 2012 JP
5084825 Nov 2012 JP
201258630 Nov 2012 JP
2012232151 Nov 2012 JP
2012528618 Nov 2012 JP
2012528619 Nov 2012 JP
2012528620 Nov 2012 JP
2012528621 Nov 2012 JP
2012528622 Nov 2012 JP
2012528623 Nov 2012 JP
2012528624 Nov 2012 JP
2012528625 Nov 2012 JP
2012528626 Nov 2012 JP
2012528627 Nov 2012 JP
2012528628 Nov 2012 JP
2012528629 Nov 2012 JP
2012528631 Nov 2012 JP
2012528632 Nov 2012 JP
2012528633 Nov 2012 JP
2012528634 Nov 2012 JP
2012528635 Nov 2012 JP
2012528636 Nov 2012 JP
2012528637 Nov 2012 JP
2012528638 Nov 2012 JP
2012528640 Nov 2012 JP
2012530576 Dec 2012 JP
2012532635 Dec 2012 JP
2012532636 Dec 2012 JP
2012532717 Dec 2012 JP
2012532720 Dec 2012 JP
2012532721 Dec 2012 JP
2012532722 Dec 2012 JP
5112330 Jan 2013 JP
5113847 Jan 2013 JP
101160735 Jul 2012 KR
20120091009 Aug 2012 KR
20120091153 Aug 2012 KR
20120091154 Aug 2012 KR
20120095919 Aug 2012 KR
20120099022 Sep 2012 KR
20120099101 Sep 2012 KR
20120102597 Sep 2012 KR
20120106754 Sep 2012 KR
20120106756 Sep 2012 KR
20120112503 Oct 2012 KR
2012006694 Jul 2012 MX
332622 Oct 2003 NO
572765 Aug 2012 NZ
587235 Aug 2012 NZ
00590352 Oct 2012 NZ
2023982 Nov 2012 PL
2274032 Oct 2012 PT
2346552 Nov 2012 PT
2462275 Mar 2011 RU
2459247 Aug 2012 RU
2011104496 Aug 2012 RU
2460546 Sep 2012 RU
2011109925 Oct 2012 RU
2011119019 Nov 2012 RU
181710 Jul 2012 SG
181790 Jul 2012 SG
184182 Oct 2012 SG
184328 Nov 2012 SG
184500 Nov 2012 SG
184501 Nov 2012 SG
184502 Nov 2012 SG
2274032 Dec 2012 SI
2346552 Dec 2012 SI
WO 8808724 Nov 1988 WO
WO 9113299 Sep 1991 WO
WO 9113430 Sep 1991 WO
WO 9219296 Nov 1992 WO
WO 9409839 May 1994 WO
WO 9411041 May 1994 WO
WO 9529720 Nov 1995 WO
WO 9529730 Nov 1995 WO
WO 9621482 Jul 1996 WO
WO 9714455 Apr 1997 WO
WO 9721457 Jun 1997 WO
WO 199741907 Nov 1997 WO
WO 9748430 Dec 1997 WO
WO 1998031369 Jul 1998 WO
WO 1998032451 Jul 1998 WO
WO 9831369 Jul 1998 WO
WO 9832451 Jul 1998 WO
WO 9903521 Jan 1999 WO
WO 9910030 Mar 1999 WO
WO 9922790 May 1999 WO
WO 9922789 May 1999 WO
WO 1999062525 Dec 1999 WO
WO 9962525 Dec 1999 WO
WO 0006228 Feb 2000 WO
WO 0024441 May 2000 WO
WO 0029050 May 2000 WO
WO 0193926 Dec 2001 WO
WO 02083216 Oct 2002 WO
WO 2002089805 Nov 2002 WO
WO 2089805 Nov 2002 WO
WO 3047663 Jun 2003 WO
03066152 Aug 2003 WO
WO 2003070296 Aug 2003 WO
WO 3068290 Aug 2003 WO
WO 03070296 Aug 2003 WO
WO 2003097133 Nov 2003 WO
WO 3097133 Nov 2003 WO
WO 2004028598 Apr 2004 WO
WO 2004041331 May 2004 WO
WO 2004047892 Jun 2004 WO
WO 2004108194 Dec 2004 WO
WO 2005005929 Jan 2005 WO
WO 20051002653 Jan 2005 WO
WO 2005009515 Feb 2005 WO
2005032623 Apr 2005 WO
WO 2005053778 Jun 2005 WO
WO 2006079064 Jul 2006 WO
WO 2006086899 Aug 2006 WO
WO 2006125328 Nov 2006 WO
WO 2006130098 Dec 2006 WO
WO 2007047200 Apr 2007 WO
WO 2007063342 Jun 2007 WO
WO 2007100899 Sep 2007 WO
WO 2006079064 Nov 2007 WO
WO 2007131013 Nov 2007 WO
WO 2007131025 Nov 2007 WO
WO 20071129106 Nov 2007 WO
WO 2007143676 Dec 2007 WO
WO 2008005315 Jan 2008 WO
WO 2008009476 Jan 2008 WO
WO 2008058666 May 2008 WO
WO 2008089886 Jul 2008 WO
WO 2008100576 Aug 2008 WO
WO 2008107378 Sep 2008 WO
WO 2008112472 Sep 2008 WO
WO 2007104636 Dec 2008 WO
2009038860 Mar 2009 WO
WO 2009049885 Apr 2009 WO
WO 2008071804 Sep 2009 WO
WO 2009114542 Sep 2009 WO
WO 2009132778 Nov 2009 WO
WO 2009141005 Nov 2009 WO
WO 2010003569 Jan 2010 WO
WO 2010043533 Apr 2010 WO
WO 2010046394 Apr 2010 WO
WO 2010097116 Sep 2010 WO
WO 2010108116 Sep 2010 WO
WO 2011023736 Mar 2011 WO
WO 2011023882 Mar 2011 WO
WO 2011035877 Mar 2011 WO
WO 2011036133 Mar 2011 WO
WO 2011036134 Mar 2011 WO
WO 2011039163 Apr 2011 WO
WO 2011039201 Apr 2011 WO
WO 2011039202 Apr 2011 WO
WO 2011039207 Apr 2011 WO
WO 2011039208 Apr 2011 WO
WO 2011039209 Apr 2011 WO
WO 2011039211 Apr 2011 WO
WO 2011039216 Apr 2011 WO
WO 2011039217 Apr 2011 WO
WO 2011039218 Apr 2011 WO
WO 2011039219 Apr 2011 WO
WO 2011039228 Apr 2011 WO
WO 2011039231 Apr 2011 WO
WO 2011039232 Apr 2011 WO
WO 2011039233 Apr 2011 WO
WO 2011039236 Apr 2011 WO
WO 2011040861 Apr 2011 WO
WO 2011045385 Apr 2011 WO
WO 2011045386 Apr 2011 WO
WO 2011045611 Apr 2011 WO
WO 2011046756 Apr 2011 WO
WO 2011048223 Apr 2011 WO
WO 2011048422 Apr 2011 WO
WO 2011050359 Apr 2011 WO
WO 2011053225 May 2011 WO
WO 2011054648 May 2011 WO
WO 2011054775 May 2011 WO
WO 2011056127 May 2011 WO
WO 2011060087 May 2011 WO
WO 2011067187 Jun 2011 WO
WO 2011067268 Jun 2011 WO
WO 2011067320 Jun 2011 WO
WO 2011067615 Jun 2011 WO
WO 2011068253 Jun 2011 WO
WO 2011069936 Jun 2011 WO
WO 2011073302 Jun 2011 WO
WO 2011073307 Jun 2011 WO
WO 2011076280 Jun 2011 WO
WO 2011080092 Jul 2011 WO
WO 2011081867 Jul 2011 WO
WO 2011081885 Jul 2011 WO
WO 2011089206 Jul 2011 WO
WO 2011089207 Jul 2011 WO
WO 2011095478 Aug 2011 WO
WO 2011095480 Aug 2011 WO
WO 2011095483 Aug 2011 WO
WO 2011095486 Aug 2011 WO
WO 2011095488 Aug 2011 WO
WO 2011095489 Aug 2011 WO
WO 2011095503 Aug 2011 WO
WO 2011099918 Aug 2011 WO
WO 2011101349 Aug 2011 WO
WO 2011101351 Aug 2011 WO
WO 2011101375 Aug 2011 WO
WO 2011101376 Aug 2011 WO
WO 2011101377 Aug 2011 WO
WO 2011101378 Aug 2011 WO
WO 2011101379 Aug 2011 WO
WO 2011101380 Aug 2011 WO
WO 2011101381 Aug 2011 WO
WO 2011101382 Aug 2011 WO
WO 2011101383 Aug 2011 WO
WO 2011107806 Sep 2011 WO
WO 2011109205 Sep 2011 WO
WO 2011110464 Sep 2011 WO
WO 2011110465 Sep 2011 WO
WO 2011110466 Sep 2011 WO
WO 2011111006 Sep 2011 WO
WO 2011112136 Sep 2011 WO
WO 2011113806 Sep 2011 WO
WO 2011117212 Sep 2011 WO
WO 2011117284 Sep 2011 WO
WO 2011117404 Sep 2011 WO
WO 2011121003 Oct 2011 WO
WO 2011121061 Oct 2011 WO
WO 2011123024 Oct 2011 WO
WO 2011124634 Oct 2011 WO
WO 2011126439 Oct 2011 WO
WO 2012020084 Feb 2012 WO
WO 2012022771 Feb 2012 WO
WO 2012090186 Jul 2012 WO
WO 2011042537 Aug 2012 WO
WO 2011042540 Aug 2012 WO
WO 2011043714 Aug 2012 WO
WO 2011051366 Sep 2012 WO
WO 2012122643 Sep 2012 WO
Non-Patent Literature Citations (51)
Entry
English Translation of Notification of Reasons for Refusal dated Sep. 20, 2016 for Japanese Patent Application No. 2014-520360.
Notification of Reasons for Refusal dated Sep. 20, 2016 for Japanese Patent Application No. 2014-520360.
International Patent Application No. PCT/US14/23883, International Search Report, dated Jul. 10, 2014, 3 pages.
International Patent Application No. PCT/US14/23485, International Search Report, dated Jul. 7, 2014, 2 pages.
International Patent Application No. PCT/US14/24530, International Search Report, dated Jul. 15, 2014, 2 pages.
International Patent Application No. PCT/US14/24543, International Search Report, dated Jul. 28, 2014, 2 pages.
“Skin”, American Medical Association (AMA) Current Procedural Terminology , 1998, http://www.ama-assn.org/ama/pub/category/print/7176.html, 1 page.
Becks et al., “Comparison of Conventional Twice-Daily Subcutaneous Needle Injections to Multiple Jet Injections of Insulin in Insulin-Dependent Diabetes”, Clinical and Investigative Medicine, 1981, p. 33B.
Binder, “Absorption of Injected Insulin”, ACTA Pharmacological ET Toxicologica, 1969, 27(Supp 2), 3 pages.
Bonetti et al., “An Extended-Release formulation of Methotrexate for Subcutaneous Administration”, Cancer Chemotherapy Pharmacology, 1994, 33, 303-306.
Braun et al., “Comparison of the Clinical Efficacy and Safety of Subcutaneous Versus Oral Administration of Methotrexate in Patients with Active Rheumatoid Arthritis”, Arthritis and Rheumatism, Jan. 2008, 58(1), pp. 73-81.
Chen et al., “Blood Lipid Profiles and Peripheral Blood Mononuclear Cell Cholesterol Metabolism Gene Expression in Patients with and Without Methotrexate” BMC Medicine, 2011, 9(4), 9 pages.
Chiasson et al., “Continuous Subcutaneous Insulin Infusion (Mill-Hill Infuser) Versus Multiple Injections (Medi-Jector) in the Treatment of Insulin-Dependent Diabetes Mellitus and the Effects of Metabolic Control on Microangiopathy” Diabetes Care, Jul.-Aug. 1984, 7(4), pp. 331-337.
Cohn et al., “Clincal Experience with Jet Insulin Injection in Diabetes Mellitus Therapy: A Clue to the Pathogenesis of Lipodystrophy”, Ala. J. Med. Sci., 1974, 11(3), pp. 265-272.
Cowie et al., “Physical and Metabolic Characteristics of Persons with Diabetes”, National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases, 1995, 95(1468), pp. 117-120.
European Patent Application No. 03707823.5, Supplementary European Search Report, dated Mar. 30, 2005 with communication dated Apr. 25, 2005 regarding Proceeding Further with the European Patent Application Pursuant to Article 96(1), and Rule 51(1) EPC, 3 pages.
European Patent Application No. 00976612.2, Communication Pursuant to Article 96(2) EPC, dated May 10, 2004, 5 pages.
Hingson et al., “A Survey of the Development of Jet Injection in Parenteral Therapy”, Nov./Dec. 1952, 31(6), pp. 361-366.
Hoekstra et al., Bioavailability of Higher Dose Methotrexate Comparing Oral and Subcutaneous Administration i n Patients with Rheumatoid Arthritis, The Journal of Rheumatology, 2004, 31(4), pp. 645-648.
International Patent Application No. PCT/US2012/46742, International Search Report and Written Opinion dated Nov. 16, 2012, 11 pages.
International Patent Application No. PCT/US2009/052835, International Search Report dated Mar. 15, 2010, 5 pages.
International Patent Application No. PCT/US2013/029085, International Search Report dated May 13, 2013, 2 pages.
International Patent Application No. PCT/US2010/028011, International Search Report, dated Jun. 29, 2010, 5 pages.
International Patent Application No. PCT/US2009/036682, International Search Report, dated Jul. 7, 2009, 5 pages.
International Patent Application No. PCT/US2007/068010, International Search Report, dated Sep. 24, 2007, 3 pages.
International Patent Application No. PCT/US03/03917, International Search Report, dated Nov. 26, 2003, 1 page.
Jansen et al., Methotrexaat Buiten de Kliniek, Pharmaceutisch Weekblad, Nov. 1999, 134(46), pp. 1592-1596.
Japanese Patent Application No. 2007-552367, Office Action dated Apr. 9, 2011.
Katoulis et al., Efficacy of a New Needleless Insulin Delivery System Monitoring of Blood Glucose Fluctuations and Free Insulin Levels, The International Journal of Artificial Organs, 1989, 12(5), 333-339.
Kurnik et al., “Bioavailability of Oral vs. Subcutaneous low-dose Methotrexate in Patients with Crohn's Disease”, Aliment Pharmacol Ther., Apr. 2003, 18, pp. 57-63.
Malone et al., “Comparison of Insulin Levels After Injection by Jet Stream and Disposable Insulin Syringe”, Diabetes care, Nov.-Dec. 1986, 9(6), 637-640.
“The Historical Development of Jet Injection and Envisioned Uses in Mass Immunization and Mass Therapy Based Upon Two Decades' Experience”, Military Medicine, Jun. 1963, 128, pp. 516-524.
Pehling et al, “Comparison of Plasma Insulin Profiles After Subcutaneous Administration of Insulin by Jet Spray and Conventional Needle Injection in Patients with Insulin-Dependent Diabetes Mellitus”, Mayo Clin. Proc., Nov. 1984, 59, pp. 751-754.
Reiss et al., “Atheroprotective Effects of Methotrexate on Reverse Cholesterol Transport Proteins and Foam Cell Transformation in Human THP-1 Monocyte/Macrophages”, Arthritis and Rheumatism, Dec. 2008, 58(12), pp. 3675-3683.
Taylor et al., “Plasma Free Insulin Profiles After Administration of Insulin by Jet and Conventional Syringe Injection”, Diabetes Care, May-Jun. 1981, 4(3), 337-339.
Weller et al., “Jet Injection of Insulin vs the Syringe-and-Needle Method”, JAMA, Mar. 1966, 195(10), pp. 844-847.
Westlake et al., “The Effect of Methotrexate on Cardiovascular Disease in Patients with Rheumatoid Arthritis: A Systematic Literature Review”, Rheumatology, Nov. 2009, 49, pp. 295-307.
Worth, “Jet Injection of Insulin: Comparison with Conventional Injection by Syringe and Needle”, British Medical Journal, Sep. 1980, 281, pp. 713-714.
International Patent Application No. PCT/US20131029085, Written Opinion, dated May 13, 2013, 5 pages.
International Patent Application No. PCT/US2010/028011, Written Opinion, dated Jun. 29, 2010, 5 pages.
Zachheim et al., “Subcutaneous Administration of Methotrexate”, Journal of the American Academy of Dermatology, 1992, 26(6), p. 1008.
Halle et al., “Twice-Daily Mixed Regular and NPH Insulin Injections with New Jet Injector Versus Conventional Syringes: Pharmacokinetics of Insulin Absorption”, Diabetes Care, May-Jun. 1986 9(3), pp. 279-282.
International Patent Application No. PCT/US2012/046639, International Search Report and Written Opinion dated Apr. 22, 2013, 8 pages.
Glynn-Barnhart et al., “Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy”, 1992, 12(5), abstract only, 2 pages.
Hamilton et al., “Why Intramuscular Methotrexate May be More Efficacious Than Oral Dosing in Patients with Rheumatoid Arthritis”, British Journal of Rheumatology, 1997, 36(1), pp. 86-90.
Stamp et al., “Effects of Changing from Oral to Subcutaneous Methotrexate on Red Blood Cell Methotrexate Polyglutamate Concentrations and Disease Activity in Patients with Rheumatoid Arthritis”, The Journal of Rheumatology, 2011, 38(12), 2540-2547.
Tukova et al., “Methotrexate Bioavailability after Oral and Subcutaneous Administration in Children with Juvenile Idiopathic Arthritis”, Clinical and Experimental Rheumatology, 2009, 27, 1047-1053.
Wright et al., “Stability of Methotrexate Injection in Prefilled Plastic Disposable Syringes”, International Journal of Pharmaceutics, Aug. 1988, 45(3), 237-244.
Lunenfeld, “Stable Testosterone Levels Achieved with Subcutaneous Testosterone Injections”, The aging Male, Mar. 2006, 9(1), 70 pages.
International Patent Application No. PCT/US2012/046639, International Search Report and Written Opinion of the International Searching Authority, dated Apr. 22, 2013. 8 pages.
Summary of Notification of Provisional Rejection dated Sep. 4, 2018 for Korean Patent Application No. 10-2014-7003621.
Related Publications (1)
Number Date Country
20160101021 A1 Apr 2016 US
Continuations (1)
Number Date Country
Parent 13184211 Jul 2011 US
Child 14973789 US